Title

New tuberculosis drug enters human trials

Document Type

Article

Department

Ophthalmology

Abstract

The Global Alliance for TB Drug Development (TB Alliance) and its partners have begum testing an experimental drug—PA-824. “[The drug's] excellent profile means its introduction into a new regimen could help shorten treatment time dramatically and overcome some of the challenges with tuberculosis treatment, such as multidrug resistance and the treatment of tuberculosis/HIV co-infected patients”, Mel Spigelman of the TB Alliance explained.

Publication

Lancet Infectious Diseases